About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

The Report

Verified funding, headquarters, and leadership news from the world's most innovative businesses

58 reports and counting

Updated daily with latest market intelligence
Fundraising
Microbiotica

Microbiotica Raises £36M Series C for Oral Microbiome Medicines

Microbiotica announced the first close of a £36 million ($48 million) Series C led by British Business Bank to advance MB310 into Phase 2 clinical development in ulcerative colitis.

SalesTools Research
Oct 16, 2026
2 min read•£36M ($48M)
Fundraising
OMass Therapeutics

OMass Therapeutics Raises $310M Series C for Small-Molecule Therapeutics

OMass Therapeutics raised an oversubscribed $310 million Series C co-led by Bain Capital Life Sciences, Forbion and Novo Holdings to advance its small molecule pipeline in endocrinology and immunology.

SalesTools Research
Oct 15, 2026
2 min read•$310M
Leadership
Harmony Biosciences

Harmony Biosciences Appoints Peter Anastasiou President and Chief Executive Officer

Harmony Biosciences appointed Chief Operating Officer Peter Anastasiou as CEO effective January 1, 2027, succeeding retiring CEO Jeffrey M. Dayno, to lead the company’s next phase of growth.

SalesTools Research
Oct 12, 2026
2 min read
Fundraising
Breye Therapeutics

Breye Therapeutics Raises €67.5M Series A for Oral Retinal Disease Drugs

Breye Therapeutics raised an over-subscribed €67.5 million Series A co-led by Mission BioCapital and Novo Holdings to advance danegaptide into a Phase 2 trial.

SalesTools Research
Sep 29, 2026
2 min read•€67.5M
Fundraising
Basecamp Research

Basecamp Research Raises $140M Series C for AI-Designed Medicines

Basecamp Research raised a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics toward clinical development.

SalesTools Research
Sep 23, 2026
2 min read•$140M
Leadership
Legend Biotech

Legend Biotech Appoints Ingrid Zhang Chief Executive Officer

Legend Biotech appointed former Novartis International Chief Commercial Officer Ingrid Zhang as CEO, succeeding Interim CEO Alan Bash, to guide the cell therapy company’s next phase of growth.

SalesTools Research
Sep 15, 2026
2 min read
Leadership
Chiesi Group

Chiesi Appoints David Khougazian Group Chief Executive Officer

Chiesi appointed former Flagship Pioneering executive David Khougazian as Group CEO, succeeding Interim Group CEO Jean-Marc Bellemin, to lead its next phase of innovation-driven growth.

SalesTools Research
Sep 15, 2026
2 min read
Leadership
Protein2o

Protein2o Names Mark Rappaport Chief Executive Officer

Protein2o appointed Mark Rappaport, most recently Global Chief Commercial Officer of Congo Brands, as Chief Executive Officer and a member of its Board of Directors, and announced a new growth investment.

SalesTools Research
Sep 8, 2026
2 min read
Leadership
Robertshaw

Robertshaw Appoints Dibyava Ghosh Chief Executive Officer

Robertshaw’s Board of Directors approved the appointment of Dibyava Ghosh, originally named President and Interim CEO in May 2026, as Chief Executive Officer.

SalesTools Research
Aug 31, 2026
2 min read
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.